You are warmly invited to attend a seminar by Professor Aton Raebelink from Leiden University Medical Centre on the clinical translation of MSCs from bench to bedside.
DATE: Monday 10 April
VENUE: Ground Floor Auditorium, Doherty Institute, Cnr Royal Pde and Grattan St, University of Melbourne
TITLE: Clinical trials with Mesenchymal Stem Cells: how to get from bench to bedside
BIO: Ton Rabelink is Professor and Chair of Medicine, and Head of the Division of Nephrology and the Einthoven Laboratory for Experimental Vascular Medicine at the Leiden University Medical Center, Leiden, Netherlands. He received his MD and PhD degrees from Utrecht University, Netherlands and completed fellowships in internal medicine and nephrology. His main research interests are vascular biology and its implications for renal function, organ transplantation and the development of cardiovascular disease in patients with renal disease, as well as the use of stem cells to restore kidney function. He is principal investigator and coordinator of an EU consortium on clinical trials using MSCs for treatment of renal disease.